Clinical genetics · 2026
Surviving Males With PORCN Variants: Expanding the Clinical, Molecular, and Mechanistic Spectrum.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Miranda-Alcaraz Lucía, Carbonera Simone, Mora-Gómez Mónica, Gallego-Zazo Natalia, Guillén Inmaculada, Padilla Elena, Visani Gaia, Asaro Alessia, Vásquez-Amell Valeria, Cazalla Mario, Rodríguez-Canó Manuel, Silván Cristina, Arias Pedro, Jiménez-Estrada Juan Andrés, Valle Tomás, Cruz-Utrilla Alejandro, Escribano-Subías Pilar, Parra Nuria Ochoa, Del Cerro Marín María Jesús, Nevado Julián, Spanish PAH Consortium, Lapunzina Pablo, Sirchia Fabio, Tenorio-Castano Jair
Аннотация
Pathogenic variants in PORCN cause focal dermal hypoplasia (FDH/Goltz syndrome), an X-linked dominant disorder historically considered lethal in males, with milder presentations now recognized as PORCN non-Goltz spectrum (PONGOS). We report three male patients identified by exome sequencing: one with a mosaic de novo variant (c.727C>T; p.Arg243*) showing FDH features, and two siblings with an inherited non-mosaic variant (c.1315T>G; p.Trp439Gly) from their unaffected carrier mother with a PONGOS phenotype. These cases confirm that male survival is possible with both mosaic and non-mosaic PORCN variants and expand the clinical and molecular spectrum of the disease. Our findings highlight the role of residual protein function in clinical variability and have important implications for diagnosis, genetic counseling, and management in families with apparently unaffected carrier mothers.